Introduction
plants (Fielder and Conrad 1995) have been developed following successful cloning of mAb encodThe widespread use of monoclonal antibodies (mAbs) ing genes. However, production of recombinant antiin immunotherapy, diagnostic tests and for in vivo bodies in mammalian and non mammalian cells is imaging and immunopurification, is the driving force hampered by the lack of fidelity of the expression for an increasing demand that could be met only if pattern and the frequent need to improve functionality large scale production techniques are mastered. To through genetic engineering of these proteins (i.e. produce large quantities of mAb, hybridoma cell lines humanization, construction of single chain variable are either injected into mice to produce ascites or fragments: ScFv, diabodies, triabodies, etc.). Consecultured using various techniques (Harlow and Lane quently, hybridoma cell line culture remains a good 1988). While production of mAbs from ascites is source for generating large quantities of mAbs that are declining because of the associated ethical and safety usually needed to assess their therapeutical or diagissues (retroviruses and mycoplasma contamination) nostic potential through in vitro and in vivo animal (Merten 1989) , other mammalian and non mamstudies before seeking approval from regulatory aumalian expression systems such as bacteria (Larochethorities and entering industrial scale production Traineau et al. 2000) , insect cells (Goosen 1993) or under GMP conditions.
Several technologies for growing hybridoma to ated tissue injury in several pathological inflammatory produce mAbs are available and range from ordinary states. flasks to spinner flasks, roller bottles and bioreactors
In this study, we applied the Taguchi's methods to (Kurkela et al. 1993) .
identify critical parameters affecting cell growth and Strategies to improve the yield of mAbs synthesis production of monoclonal antibody 23G11 by a hyat large scale are being developed for each system bridoma cell line. (Yang et al. 2000; Kurkela et al. 1993; Dhir et al. 2000) .
For conventional optimization strategies, each variMaterials and methods able to be studied requires independent testing. Thus to perform an optimization study it is necessary to Cell line (Hybridoma): the 23G11 murine hybridoma conduct a large number of costly and labor intensive was used throughout this study. This cell line experiments.
produces an IgG2a monoclonal antibody. The Taguchi approach uses a number of progresMedia: The cells were cultivated in two media sive trials to examine simultaneously several factors RPMI-1640 (Life Technologies, ref. 13018 ) (medium and to identify rapidly those that have major effects 1) and RPMI-1640 supplemented with glucose and (Taguchi 1986). These control factors are then used to glutamine up to final concentrations of 16.67 mM and predict a combination that will lead to the optimal 4 mM respectively (medium 2). These media were performance (Aujame et al. 2000; Han et al. 1998 of a process by performing the minimum number of were inoculated with 2 3 10 cells ml . The experiexperiments possible. A trial to study the effect and ments were carried out in duplicate. Samples were interaction of four factors at 2 levels each would taken daily for cell count and for the measurement of 4 require 16 experiments (2 ). However, by using glucose, lactate, pH and antibody levels. Taguchi's methods this study can be carried out by performing only eight experiments. The more comAnalytical methods ponents and interactions that need to be investigated, the more it becomes worth using this type of ex-
The viable and total cell concentrations were deterperimental design. As an example, by using the mined using a hemacytometer and the trypan blue Taguchi approach only 12 experiments would be exclusion method. necessary to test 8 factors and 3 interactions, instead
21
The specific growth rate, m (h ) was estimated by of 256 experiments for a full plan analysis. Taguchi's the following equation: methods have found widespread use in industrial process design, principally in development trials.
However, besides protein expression in the baculovirus system (Burch et al. 1995) , few biotechnologiwhere X represents the viable cell density per ml, t cal processes have so far benefited from the Taguchi represents the time points of sampling expressed in h; approach in their development phases.
the subscripts 1 and 2 stand for two succeeding In a previous work, we selected a hybridoma cell sampling points.
-1 line that produces high levels (0.5 mg ml ) of a Glucose and lactic acid concentrations were monimouse mAb (23G11) directed specifically against a tored by enzymatic assays, using glucose assay kit recombinant form of the b integrin alpha subunit and lactate assay kit from Chronolab (Switzerland).
2 CD11b, A-domain. The A-domain is a 200 amino-ELISA test: Immulon-2 ELISA plates were coated acid peptide present within structurally diverse with recombinant protein, CD11b A-domain (2 mg / proadhesive proteins. Anti-integrin antibodies carry a well) at 37 8C for 1 h. Plates were washed once with therapeutic potential in controlling leukocyte-medi-PBS buffer, then blocked with 1% BSA at room The factor levels are shown in each experiment. On the left-hand side, the numbers indicate the experiments, and the letters at the top of the columns indicate the factors (variables).
temperature for 1 h. After washing three times with the tabulated value (F9), determined from the Fisher-0.05% Tween 20, plates were incubated with mAb Snedecor table at the p 5 0.05 level. 23G11 (hybridoma culture supernatant diluted with PBS-1%BSA) at room temperature for 1 h. After incubation, plates were washed three times, then
Results and discussion incubated with a second mAb, goat anti mouse IgG conjugated with alkaline phosphatase (Sigma) at room
In this work, we studied the effect on cell growth and temperature for 1 h. Plates were then washed three monoclonal antibody production, by a hybridoma cell times and incubated with the alkaline phosphatase line, of four factors which are: stirring speed (factor substrate: o-phenylenediamine / H O (Sigma) for 30 A), nature of serum (factor B), concentration of serum 2 2 min at room temperature. The results were quantified (factor C) and the nature of medium (factor D). using an ELISA plate reader at 405 nm.
Furthermore, we investigated the interactions between the stirring speed / nature of serum, the stirring speed / concentration of serum and the nature of serum / conTaguchi's orthogonal design centration of serum.
As shown in Table 4 , for each factor and interaction The Taguchi experiments followed an experimental studied, we calculated the effect, determined the layout called the L8 array (Table 1) .
variance and calculated the F values which were We chose the L8 array because it allows invescompared to the tabulated values retrieved form the tigation of the effect of four factors and 3 interactions Fisher-Snedecor table (F9). at once. The levels of the components used in the L8
It should be noted that studying 3 factors and 4 Taguchi's orthogonal array are shown in Table 2 .
interactions using an L8 orthogonal array, does not To determine the significance of the effect of each leave any degree of freedom to estimate the residual factor and interaction studied, an ANOVA table was error (R). constructed. The variance of each parameter was calculated. The F value was used to test the signifiOptimization of cell growth cance of the factor. A factor is considered as having a major effect if the calculated value (F) is higher than For experiments 1, 2, 3, 4, 6 and 8, typical batch growth curves were obtained (Figure 1 ). We observed density indicated that for all the experiments per-(concentration of serum) as well as the interaction formed, cell growth was not limited by this nutrient as between these two factors (AC) have a significant shown in Figure 1a and b. Cells stopped growing even effect on the cell growth. though glucose was not exhausted from the medium.
The cell growth was related to the significant This suggests that the cessation of cell growth could variables using the following linear equation: be due either to a limitation by another nutrient, like Cell density (Cells per ml)5 glutamine, or to the accumulation of toxic metaboX1h x A1h x C1h x AC A C A C lites, such as lactate or ammonia. Lactate production curves indicated in Figure 1c Where X is the average cell density obtained in the show that the level reached for all the experiments eight experiments. h , h and h stand respectively was lower than the levels reported for several hybrid-
for the effects of factors A, C and the interaction oma cell lines (Sanfeliu et al. 1995; Miller et al. between factors A and C. 1988). In our study, the highest lactate levels were Our data show that for optimal cell growth, factor observed in experiments 1 and 6, which corresponded A (stirring speed) should be set at level 1 (i.e. 30 to the highest specific growth rates. rpm) and factor C (serum concentration) at level -(i.e. The statistical analysis of the kinetic parameters 10%). was carried out according to the methods used by Taguchi.
The calculation of the variance for each factor and Optimization of production of monoclonal interaction studied shows that the lowest values were antibodies obtained for the following factors: the nature of serum and the type of medium. This indicates that these To estimate the yield of the antibody production factors did not have a significant effect on cell denthroughout the optimization trials, we used a direct sity. Thus, they were ignored and their effects were specific ELISA test. For each trial, several dilutions of pooled and considered as a residual error (R). The the cell culture supernatant, harvested daily, were calculations based on these observations are presented tested. The concentration of monoclonal antibody -1 in Table 4 . (mg ml ) was deduced from a standard curve conThe analysis of the ANOVA table (Table 4) showed structed using purified monoclonal antibody 23G11 that only factor A (stirring speed), and factor C with a known concentration. for the experiment j. The level used for each factor at the corresponding experiment is indicated in Table 1. antibody production was performed according to the method detailed above. The results obtained, shown in Table 5 , indicate that the following factors: stirring speed, concentration of serum, nature of medium, and the following interactions stirring speed / nature of serum and stirring speed / concentration of serum, have a significant effect on the production of monoclonal antibody by the hybridoma cell line used. These observations strongly suggest that the stirring speed and the concentration of serum used are critical parameters that affect both cell growth and monoclonal antibody production, and that synthesis of monoclonal antibody is more affected by environmental conditions than by cell growth.
The modelling of the monoclonal antibody production according to Taguchi These data show that to optimize monoclonal antibody 23G11 production levels, RPMI 1640 enriched with glucose and glutamine should be used. Stirring speed and serum concentration should be respectively set at 30 rpm and 10%. antibodies by hybridoma cell lines culture is affected by the operating conditions, such as glucose and The levels of monoclonal antibodies obtained in the glutamine concentrations, osmolarity and pH (Miller eight experiments are presented in Figure 2 . et al. 1988; Oyaas et al. 1994; Maier et al. 1995 ; The statistical treatment related to monoclonal Sanfeliu et al. 1995) . In our study, higher glucose and glutamine concentrations seemed to enhance monoclonal antibody production and not cell density. This could be explained by the increase of osmolarity, which stimulates monoclonal antibodies synthesis, and not cell growth. For the cell line studied, we observed that the level of monoclonal antibody 23G11 produced is not associated with cell growth (see Figures 1, 2) . Such behavior has been observed with other hybridoma cell lines in different studies (Miller et al. 1988; Merten 1989) . line in spinner flasks.
Conclusion
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